CSafe

APS

A New Pinnacle in Advanced Pallet Shipping

Find out more

02/23/2024 23:28:26
  • Home | Medicine in outer space
  • In this issue
  • Contents
  • CSafeAPS
  • Agilent
  • Briefing
  • Industry news
  • The pharma industry briefing
  • Pfeiffer Vacuum
  • Mimotopes Company Insight
  • Mimotopes
  • Allpack group ag
  • Comment
  • Sandoz spin-off continues Novartis’ focus on innovation
  • High risk, high reward – the future of CAR-T therapy in CLL
  • bluebird bio bags landmark FDA approvals for gene therapies
  • Covid-19 vaccine companies boosted with over 80% revenue growth
  • Urgent need to update Canada’s breast cancer screening guidelines
  • The epidemiology of RSV changed in UK children during the pandemic
  • Zenatek Company Insight
  • BEA Technologies
  • In Depth
  • Medicine in outer space: drug development, manufacturing, and beyond
  • Oncology therapies dominate the orphan drug landscape
  • How environmental factors could influence disease and drugs
  • Joining the dots: How gene regulatory network tools are unearthing drugs
  • Inflation drives pharma manufacturing focus on sustainability
  • What do remote assessments mean for sponsors?
  • CMO Moves: Regulatory catalysts for drug manufacturing-October
  • Tripletree
  • In Data
  • Data analytics hiring levels in the pharma industry fell to a year-low in August
  • Pharma found it easier to fill cloud vacancies in Q2 of 2022
  • Pharma filings see a 56% increase in big data mentions since Q2 of 2021
  • Industrial automation hiring levels in pharma rose in August 2022
  • Events
  • Next issue
10/20/2022 00:00:00